Davis ME. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2–8. https://doi.org/10.1188/16.CJON.S1.2-8.

Article  PubMed  Google Scholar 

Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381–97. https://doi.org/10.1016/B978-0-12-802997-8.00023-2.

Article  PubMed  Google Scholar 

Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299–312. https://doi.org/10.3322/caac.21613.

Article  PubMed  Google Scholar 

Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol. 2010;67(3):279–83. https://doi.org/10.1001/archneurol.2010.

Article  PubMed  Google Scholar 

Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin K-M, Westhoff M-A. Temozolomide and other alkylating agents in glioblastoma therapy. Biomedicines. 2019;7(3):69. https://doi.org/10.3390/biomedicines7030069.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764–72. https://doi.org/10.1158/1078-0432.CCR-12-3002.

Article  CAS  PubMed  Google Scholar 

Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108(1):11–27. https://doi.org/10.1007/s11060-011-0793-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445–53. https://doi.org/10.2353/ajpath.2007.070011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129(6):829–48. https://doi.org/10.1007/s00401-015-1432-1.

Article  CAS  PubMed  Google Scholar 

Alexiou GA, Voulgaris S. The role of the PTEN gene in malignant gliomas. Neurol Neurochir Pol. 2010;44(1):80–6. https://doi.org/10.1016/s0028-3843(14)60408-4.

Article  PubMed  Google Scholar 

Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamgüney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007;9(3):271–9. https://doi.org/10.1215/15228517-2007-003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koul D. PTEN signaling pathways in glioblastoma. Cancer Biol Ther. 2008;7(9):1321–5. https://doi.org/10.4161/cbt.7.9.6954.

Article  CAS  PubMed  Google Scholar 

Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I. Epidemiology of glioblastoma multiforme-literature review. Cancers. 2022;14(10):2412. https://doi.org/10.3390/cancers14102412.

Article  PubMed  PubMed Central  Google Scholar 

Zhang R, Li G, Zhang Q, et al. Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cells. Cell Death Dis. 2018;9:598. https://doi.org/10.1038/s41419-018-0641-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127–50. https://doi.org/10.1146/annurev.pathol.4.110807.09231.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu C, Zhou H, Liu Y, Huang J, Liu W, Zhang Q, Tang Q, Sheng F, Li G, Zhang R. ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN/PI3K/FAK pathway. Int J Oncol. 2019;55(4):833–44. https://doi.org/10.3892/ijo.2019.4864.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zakaria MA, Rajab NF, Chua EW, Selvarajah GT, Masre SF. Roles of Rho-associated kinase in lung cancer. Int J Oncol. 2021;58(2):185–98. https://doi.org/10.3892/ijo.2020.5164.

Article  CAS  PubMed  Google Scholar 

Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel insights into the roles of Rho kinase in cancer. Arch Immunol Ther Ex. 2016;64(4):259–78. https://doi.org/10.1007/s00005-015-0382-6.

Article  CAS  Google Scholar 

Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 2011;29(8):1259–66. https://doi.org/10.1002/jor.21403.

Article  CAS  PubMed  Google Scholar 

Amaya CN, Mitchell DC, Bryan BA. Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth. BMC Cancer. 2017;17(1):485. https://doi.org/10.1186/s12885-017-3470-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nie Y, Zhu X, Bu N, Jiang Y, Su Y, Pan K, Li S. Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression. BMC Cancer. 2022;22:265. https://doi.org/10.1186/s12885-022-09323-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You Y, Zhu K, Wang J, Liang Q, Li W, Wang L, Guo B, Zhou J, Feng X, Shi J. ROCK inhibitor: focus on recent updates. Chin Chem Lett. 2023;34(12):108336. https://doi.org/10.1016/j.cclet.2023.108336.

Article  CAS  Google Scholar 

Wu Q, Ouyang C, Xie L, Ling Y, Huang T. The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial-to-mesenchymal transition/epithelial-to-mesenchymal transition and increases ionic transporter expression. Int J Mol Med. 2017;40(4):1009–18. https://doi.org/10.3892/ijmm.2017.3103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chapman S, McDermott DH, Shen K, Jang MK, McBride AA. The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional. Stem Cell Res Ther. 2014;5(2):60. https://doi.org/10.1186/scrt449.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson JM, Nguyen QH, Singh M, Pavesic MW, Nesterenko I, Nelson LJ, Liao AC, Razorenova OV. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma. Oncogene. 2017;36(8):1080–9. https://doi.org/10.1038/onc.2016.272.

Article  CAS  PubMed  Google Scholar 

Horáková K, Šovčı́ková A, Seemannová Z, Syrová D, Bušányová K, Drobná Z, Ferenčı́k M. Detection of drug-induced, superoxide-mediated cell damage and its prevention by antioxidants. Free Radic Biol Med. 2001;30(6):650–64. https://doi.org/10.1016/S0891-5849(00)00508-6.

Article  PubMed  Google Scholar 

Urcan E, Haertel U, Styllou M, Hickel R, Scherthan H, Reichl FX. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent Mater. 2010;26(1):51–8. https://doi.org/10.1016/j.dental.2009.08.007.

Article  CAS  PubMed  Google Scholar 

Wu XL, Liu L, Wang QC, Wang HF, Zhao XR, Lin XB, Mei QB. Antitumor activity and mechanism study of riluzole and its derivatives. Iran J Pharm Res. 2020;19(3):217. https://doi.org